Proof-of-concept study demonstrates novel strategy to develop liver-targeting chimeras for disease treatment
Liver cancer ranks as the fourth most common cancer and the second leading cause of cancer-related deaths in China, with hepatocellular carcinoma (HCC) being the most prevalent type. Current treatments for liver cancer encounter ...
Sep 10, 2024
0
0